Tradestie Institutional Equity Comparison Engine

IMDX vs FLGT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

FLGT Overall Edge

FLGT Captures Institutional Edge (4โ€“0 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Fulgent Genetics, Inc. Common Stock (FLGT) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, IMDX trades at N/M Forward P/E with -1883.2% operating margin (+115.0% YoY revenue) versus FLGT at 7.7x Forward P/E and -37.1% operating margin (+7.5% YoY). In options structure, IMDX sits in BREAKDOWN (12th %ile IV; Dealer Gamma Walls on Pro) against FLGT sits in BREAKOUT (9th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner FLGT
IMDX N/M vs FLGT 7.7x Fwd P/E
Growth & Margin Winner FLGT
Op Margin -1883.2% vs -37.1% ยท YoY +115.0% vs +7.5%
Momentum & Technical Winner FLGT
1Y -73.8% vs -14.8% ยท 52W Pos 3% vs 64%
Options & Structure Winner FLGT
BREAKDOWN (12th %ile IV) vs BREAKOUT (9th %ile IV)
IMDX NASDAQ
Insight Molecular Diagnostics Inc. Common Stock
In Vitro & In Vivo Diagnostic Substances
$1.66
+4.4% 1D
Market Cap $52.1M
1M Return -45.03%
1Y Return -73.78%
Forward P/E N/M
Unified AI Score
45.5 / 100 HOLD
Tech 50.0 Fund 40.0 Flow 58.0 Mom 40.0
FLGT NASDAQ
Fulgent Genetics, Inc. Common Stock
Services-Medical Laboratories
$24.78
-1.39% 1D
Market Cap $708.5M
1M Return +23.1%
1Y Return -14.85%
Forward P/E 7.7x
Unified AI Score
33.7 / 100 SELL
Tech 50.0 Fund 32.0 Flow 58.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IMDX -73.78% FLGT -14.85% Spread: +58.93 pp (FLGT Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period IMDX Revenue FLGT Revenue IMDX Op. Margin FLGT Op. Margin Margin Edge
FY2018 N/A $20M N/A -23.7% FLGT
FY2019 N/A $30M N/A -1.3% FLGT
FY2020 $0M $420M -2443.3% 68.8% FLGT
FY2021 $0M $990M -2444.3% 68.1% FLGT
FY2022 $0M $620M -1878.6% 28.8% FLGT
FY2023 $0M $290M -1672.4% -67.6% FLGT
FY2024 $0M $280M -3245.1% -26.1% FLGT
FY2025 $0M $320M -1260.8% -28.2% FLGT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IMDX (4) vs FLGT (6)
Institutional Metric IMDX FLGT Criterion Row Winner
Market Capitalization Scale $52.1M $708.5M Larger Scale FLGT
Trailing P/E Ratio Valuation N/M 7.7x Lower Multiple FLGT
Forward P/E Ratio Valuation N/M 7.7x Lower Multiple FLGT
Revenue Growth (YoY) Growth +115.0% +7.5% Higher Growth IMDX
Operating Margin (TTM) Profitability -1883.2% -37.1% Higher Margin FLGT
Net Profit Margin Profitability 0.0% -27.5% Higher Margin IMDX
Return on Equity (ROE) Capital Efficiency -23603.1% -8.7% Higher ROE FLGT
52-Week Range Position Momentum 3% ($2โ€“$8) 64% ($13โ€“$31) Stronger Trend FLGT
Beta / 30D Volatility Risk Regime 2.91ฮฒ ยท 76% Vol 1.13ฮฒ ยท 108% Vol Lower Realized Risk IMDX
Unified Institutional Score Composite Signal 45.5 / 100 (HOLD) 33.7 / 100 (SELL) Higher Composite IMDX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IMDX vs FLGT Buy Guide
IMDX BREAKDOWN
117d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 12th %ile
IV Regime Compressed (<25th %ile)
Live IMDX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
FLGT BREAKOUT
97d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 9th %ile
IV Regime Compressed (<25th %ile)
Live FLGT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IMDX nor FLGT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.